Rep Kelly Morrison sells up to $140K in Accenture stock
- Rep Kelly Morrison sold Accenture stock valued between $21,007 and $140,000
- Transaction date was August 11, 2026, filed in August per STOCK Act rules
- Accenture shares traded at $182.25, down 3.04% at the time of reporting
- Congressional sales do not necessarily indicate bearish market sentiment

*this image is generated using AI for illustrative purposes only.
Minnesota Representative Kelly Morrison sold Accenture (NYSE: ACN) shares valued between $21,007 and $140,000. The transaction took place on August 11, 2026, according to records filed in August.
As of the report date, Accenture shares were trading at $182.25, down 3.04%.
Regulatory Context
The sale falls under the disclosure requirements of the STOCK Act, signed into law by President Barack Obama in April 2012. The legislation prohibits members of Congress from using non-public information for personal gain and mandates timely public reporting of transactions.
Representatives must file a Periodic Transaction Report within 30 days of being notified of the trade and within 45 days of the transaction date. Morrison’s filing adheres to these timelines.
Market Implications
Congressional trades are often monitored by investors for potential signals regarding market sentiment. However, regulatory filings do not indicate whether a sale reflects bearish views or portfolio rebalancing.
- Sales may stem from diversification needs or liquidity requirements rather than negative outlooks.
- Purchases might suggest confidence in future price appreciation.
- Investors are advised to treat such data as one factor among many, not a primary decision driver.
What the Numbers Show
The disclosed value range is wide, spanning nearly seven times from the lower bound ($21,007) to the upper bound ($140,000). This variance is typical for congressional disclosures where exact share counts or average prices are not always specified in initial filings, leaving the precise economic exposure ambiguous.
How might this sale influence retail investor sentiment toward Accenture given the stock's recent 3% decline?
Are there other congressional members who have recently adjusted their positions in Accenture or similar IT consulting firms?
Could the wide valuation range in Morrison's filing indicate a partial liquidation strategy rather than a full exit from the position?
































